Brokerages Set Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Target Price at $17.25
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a buy rating and one has given a strong buy […]
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a buy rating and one has given a strong buy […]
